Premium
Premium statistics

Industry-specific and extensively researched technical data (partially from exclusive partnerships).

A paid subscription is required for full access.

Loss through small molecule patent expiries in developed pharmaceutical markets from 2011 to 2020 (in billion U.S. dollars)

Exclusive Premium Statistic

Small molecules facing loss of developed market exclusivity 2011-2020 This statistic shows the loss through small molecule patent expiries in developed pharmaceutical markets from 2011 to 2020. In 2011, there was a total loss in exclusivity of 16 billion U.S. dollars among small molecule products in developed markets. Patent expiries reached a peak in 2012 when Lipitor, Plavix, Singulari, and Seroquel experienced competition from generics in the United States.
Show more
Exclusive Premium statistic

Get a Premium Account for unrestrained access.
Benefits of our Premium membership:

  • Access to all Premium statistics
  • Download as XLS, PNG and PDF
  • Detailed source and background information
Premium Account
$49 per month*
(billed annually)
*Single license

Access to this and all other statistics on 80,000 topics from

$588 / Year

View price details

Loading statistic...
Lost value in billion U.S. dollars
--
--
--
--
--
--
--
--
--
--
Lost value in billion U.S. dollars
--
--
--
--
--
--
--
--
--
--
Exclusive Premium statistic

Get a Premium Account for unrestrained access.
Benefits of our Premium membership:

  • Access to all Premium statistics
  • Download as XLS, PNG and PDF
  • Detailed source and background information
Premium Account
$49 per month*
(billed annually)
*Single license

Access to this and all other statistics on 80,000 topics from

$588 / Year

View price details

© Statista 2017

Download Settings Share
Chart type
Datalabels
Share on Social Media
Download started
Please be patient - this may take a moment
Description Source More information
This statistic shows the loss through small molecule patent expiries in developed pharmaceutical markets from 2011 to 2020. In 2011, there was a total loss in exclusivity of 16 billion U.S. dollars among small molecule products in developed markets. Patent expiries reached a peak in 2012 when Lipitor, Plavix, Singulari, and Seroquel experienced competition from generics in the United States.
Show more
Release date
November 2015
Region
World
Survey time period
2011 to 2015
Special properties
developed countries
Supplementary notes
* From 2015 on projected.

Statista Accounts: Access All Statistics. Starting from $588 / Year

Statistics on "Global pharmaceutical industry"

  • Overview
The most important statistics
  • Companies and products
The most important statistics
  • Top companies by revenue
  • R&D, patents, new entities
  • Outlook
The most important statistics

Related Studies: Available to Download in PDF or PPTX Format

Global pharmaceutical industry

All Information
in one Presentation

Global pharmaceutical industry

Everything On "Global pharmaceutical industry" in One Document: Edited and Divided into Handy Chapters. Including Detailed References.

Statista for Your Company: The Research and Analysis Tool

  • Product Film
  • Statistics
  • Downloads

Our Premium Statistics - facts for your business

Currently, Statista provides more than 1 million statistics.
93 percent (all Premium content) are exclusively accessible via our professional accounts.

Unlimited access

As a Statista Premium customer, you receive unlimited access to all statistics at all times. Including downloads of data in the most common formats (XLS, PDF & PNG). Create relevant and significant statistics in no time.

You are in good company

Further Content: Statistics, Studies, and Topic Pages

Our Business Solutions: Save Time and Money

only

$588*

per year
Your advantages
  • Full access to all our statistics
  • Download as XLS, PDF & PNG
  • Relevant data: complete source information
All functions of our platform illustrated face-to-face
  • Learn how Statista supports your company
  • Extensive tour across the whole portal
  • Personal guidance by our support team
The knowledge database for your company
  • All functions of the Premium Account
  • Access to dossiers, forecasts and studies
  • Access to our international database
  • Publishing rights and other exclusive functions

Statistics on the topic

Topics

About Statista

Learn more about how Statista can support your business.

Request webinar